Fertility and Pregnancy-Related Issues in Young Carriers With Breast Cancer

Autor: Isotta Martha Magaton, Luca Arecco, Elene Mariamidze, Kristina Jankovic, Mihaela Stana, Giulia Buzzatti, Lucia Trevisan, Graziana Scavone, Silvia Ottonello, Piero Fregatti, Claudia Massarotti, Michael von Wolff, Matteo Lambertini

Publikováno v: Breast Cancer: Basic and Clinical Research, Vol 18 (2024)

Approximately 10% to 15% of breast cancer cases in young women are diagnosed in patients harbouring germline (g) pathogenic or likely pathogenic variants (PVs) in the BReast CAncer 1 ( BRCA1 ) or BReast CAncer 2 ( BRCA2 ) genes. Preclinical and clini

Externí odkaz: https://doaj.org/article/5f578ab592f942699ba2ea22e7cd9fc5

The Value of Offering Oncofertility Counseling in Young Patients With Newly Diagnosed Cancer Is Unquestionable.

Autor: Arecco L; Luca Arecco, MD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Brussels, Belgium; Abeid Omar, MD, Department of Clinical Oncology, Kenyatta University Teaching, Referral and Research Hospital (KUTRRH), Nairobi, Kenya; Luciana de Moura Leite, MD, Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil; Kristina Janković, MD, Clinic of Oncology, University Clinical Center Nis, Nis, Serbia; Gabriella Gentile, MD, Department of Radiological, Oncological and Pathological Sciences, Sapienza-University of Rome, Rome, Italy; Mihaela Stana, MD, Department of Medical Oncology, Elysée Hospital, Alba Iulia, Romania; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; and Matteo Lambertini, MD, PhD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Omar A; Luca Arecco, MD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Brussels, Belgium; Abeid Omar, MD, Department of Clinical Oncology, Kenyatta University Teaching, Referral and Research Hospital (KUTRRH), Nairobi, Kenya; Luciana de Moura Leite, MD, Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil; Kristina Janković, MD, Clinic of Oncology, University Clinical Center Nis, Nis, Serbia; Gabriella Gentile, MD, Department of Radiological, Oncological and Pathological Sciences, Sapienza-University of Rome, Rome, Italy; Mihaela Stana, MD, Department of Medical Oncology, Elysée Hospital, Alba Iulia, Romania; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; and Matteo Lambertini, MD, PhD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., de Moura Leite L; Luca Arecco, MD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Brussels, Belgium; Abeid Omar, MD, Department of Clinical Oncology, Kenyatta University Teaching, Referral and Research Hospital (KUTRRH), Nairobi, Kenya; Luciana de Moura Leite, MD, Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil; Kristina Janković, MD, Clinic of Oncology, University Clinical Center Nis, Nis, Serbia; Gabriella Gentile, MD, Department of Radiological, Oncological and Pathological Sciences, Sapienza-University of Rome, Rome, Italy; Mihaela Stana, MD, Department of Medical Oncology, Elysée Hospital, Alba Iulia, Romania; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; and Matteo Lambertini, MD, PhD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Janković K; Luca Arecco, MD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Brussels, Belgium; Abeid Omar, MD, Department of Clinical Oncology, Kenyatta University Teaching, Referral and Research Hospital (KUTRRH), Nairobi, Kenya; Luciana de Moura Leite, MD, Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil; Kristina Janković, MD, Clinic of Oncology, University Clinical Center Nis, Nis, Serbia; Gabriella Gentile, MD, Department of Radiological, Oncological and Pathological Sciences, Sapienza-University of Rome, Rome, Italy; Mihaela Stana, MD, Department of Medical Oncology, Elysée Hospital, Alba Iulia, Romania; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; and Matteo Lambertini, MD, PhD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Gentile G; Luca Arecco, MD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Brussels, Belgium; Abeid Omar, MD, Department of Clinical Oncology, Kenyatta University Teaching, Referral and Research Hospital (KUTRRH), Nairobi, Kenya; Luciana de Moura Leite, MD, Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil; Kristina Janković, MD, Clinic of Oncology, University Clinical Center Nis, Nis, Serbia; Gabriella Gentile, MD, Department of Radiological, Oncological and Pathological Sciences, Sapienza-University of Rome, Rome, Italy; Mihaela Stana, MD, Department of Medical Oncology, Elysée Hospital, Alba Iulia, Romania; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; and Matteo Lambertini, MD, PhD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Stana M; Luca Arecco, MD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Brussels, Belgium; Abeid Omar, MD, Department of Clinical Oncology, Kenyatta University Teaching, Referral and Research Hospital (KUTRRH), Nairobi, Kenya; Luciana de Moura Leite, MD, Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil; Kristina Janković, MD, Clinic of Oncology, University Clinical Center Nis, Nis, Serbia; Gabriella Gentile, MD, Department of Radiological, Oncological and Pathological Sciences, Sapienza-University of Rome, Rome, Italy; Mihaela Stana, MD, Department of Medical Oncology, Elysée Hospital, Alba Iulia, Romania; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; and Matteo Lambertini, MD, PhD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Azim HA Jr; Luca Arecco, MD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Brussels, Belgium; Abeid Omar, MD, Department of Clinical Oncology, Kenyatta University Teaching, Referral and Research Hospital (KUTRRH), Nairobi, Kenya; Luciana de Moura Leite, MD, Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil; Kristina Janković, MD, Clinic of Oncology, University Clinical Center Nis, Nis, Serbia; Gabriella Gentile, MD, Department of Radiological, Oncological and Pathological Sciences, Sapienza-University of Rome, Rome, Italy; Mihaela Stana, MD, Department of Medical Oncology, Elysée Hospital, Alba Iulia, Romania; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; and Matteo Lambertini, MD, PhD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Lambertini M; Luca Arecco, MD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Brussels, Belgium; Abeid Omar, MD, Department of Clinical Oncology, Kenyatta University Teaching, Referral and Research Hospital (KUTRRH), Nairobi, Kenya; Luciana de Moura Leite, MD, Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil; Kristina Janković, MD, Clinic of Oncology, University Clinical Center Nis, Nis, Serbia; Gabriella Gentile, MD, Department of Radiological, Oncological and Pathological Sciences, Sapienza-University of Rome, Rome, Italy; Mihaela Stana, MD, Department of Medical Oncology, Elysée Hospital, Alba Iulia, Romania; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; and Matteo Lambertini, MD, PhD, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2024 Nov 22, pp. OP2400634. Date of Electronic Publication: 2024 Nov 22.